The trial also revealed statistically significant and clinically meaningful gains in key patient-reported outcomes
Preclinical studies show that 4P004 modulates multiple biological markers across the joint, potentially slowing structural damage while improving function
Appointment supports AstraZeneca’s $50 billion US investment and ambition to reach $80 billion in Total Revenue by 2030
The current two-vial format requires healthcare professionals to mix a lyophilised antigen with a liquid adjuvant before administration
REDEMPLO is the first and only Health Canada-approved siRNA therapy for FCS
Valneva said regaining full rights to the vaccine will allow the company to “assume direct control over its supply chain and commercialization for endemic high-risk countries
The surgical team used LD Flap Reconstruction, a specialised technique that rebuilt elbow strength and movement
The trials did not show a statistically significant reduction in annualized clinical fracture rates compared to placebo or bisphosphonates
TMS offers new hope to patients suffering from stroke, migraine, neuropathic pain, depression, and other disorders
Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
Subscribe To Our Newsletter & Stay Updated
